We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$3.38B
AUM Growth
+$357M
Cap. Flow
+$11.3M
Cap. Flow %
0.33%
Top 10 Hldgs %
28.56%
Holding
841
New
147
Increased
207
Reduced
242
Closed
138
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
151
Mondelez International
MDLZ
$77.1B
$4.24M 0.13%
58,530
-155
-0.3% -$10.6K
SPTL icon
152
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.4B
$4.2M 0.12%
144,610
+22,177
+18% +$591K
NEE icon
153
NextEra Energy
NEE
$187B
$4.12M 0.12%
67,867
-15,323
-18% -$873K
IQLT icon
154
iShares MSCI Intl Quality Factor ETF
IQLT
$13.6B
$4.11M 0.12%
109,395
+254
+0.2% +$8.86K
ALL icon
155
Allstate
ALL
$65.5B
$4.08M 0.12%
29,155
-195
-0.7% -$25.4K
VRNS icon
156
Varonis Systems
VRNS
$5.14B
$4.07M 0.12%
89,825
+16,785
+23% +$631K
EFAX icon
157
State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF
EFAX
$490M
$4.04M 0.12%
103,475
+7,773
+8% +$283K
CAT icon
158
Caterpillar
CAT
$412B
$3.96M 0.12%
13,378
-3,196
-19% -$829K
EMR icon
159
Emerson Electric
EMR
$81.2B
$3.87M 0.11%
39,754
+34
+0.1% +$3.11K
NXPI icon
160
NXP Semiconductors
NXPI
$70B
$3.81M 0.11%
16,602
-2,599
-14% -$523K
ITW icon
161
Illinois Tool Works
ITW
$79.7B
$3.8M 0.11%
14,492
+731
+5% +$175K
VIS icon
162
Vanguard Industrials ETF
VIS
$8.22B
$3.78M 0.11%
17,141
-519
-3% -$105K
EW icon
163
Edwards Lifesciences
EW
$48.3B
$3.77M 0.11%
49,413
-7,218
-13% -$502K
P
164
Everpure Inc
P
$25B
$3.71M 0.11%
103,979
+8,293
+9% +$291K
UNP icon
165
Union Pacific
UNP
$181B
$3.68M 0.11%
14,992
+256
+2% +$56.3K
MDYV icon
166
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.73B
$3.68M 0.11%
50,113
+1,226
+3% +$81.1K
IUSV icon
167
iShares Core S&P US Value ETF
IUSV
$26.9B
$3.65M 0.11%
43,279
-401
-0.9% -$31.2K
VZ icon
168
Verizon
VZ
$183B
$3.59M 0.11%
95,167
-5,315
-5% -$188K
NOC icon
169
Northrop Grumman
NOC
$75.8B
$3.48M 0.1%
7,433
-44
-0.6% -$20.6K
MDY icon
170
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$3.41M 0.1%
6,720
+2
+0% +$929
TMO icon
171
Thermo Fisher Scientific
TMO
$213B
$3.41M 0.1%
6,417
-23
-0.4% -$11.1K
VDC icon
172
Vanguard Consumer Staples ETF
VDC
$7.78B
$3.36M 0.1%
17,595
+130
+0.7% +$23.9K
SYK icon
173
Stryker
SYK
$122B
$3.32M 0.1%
11,095
-342
-3% -$96K
IGRO icon
174
iShares International Dividend Growth ETF
IGRO
$1.26B
$3.28M 0.1%
50,783
+243
+0.5% +$14.7K
DDOG icon
175
Datadog
DDOG
$87B
$3.26M 0.1%
26,865
-3,340
-11% -$344K

Similar funds

Bailard's Q4 2023 Portfolio in Review

As of Q4 2023, Bailard held 841 positions worth $3.38B, up 12% from $3.02B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bailard's Q4 2023 filing shows 147 new, 207 increased, 242 reduced and 138 closed positions. Its largest new stake was Vanguard Tax-Exempt Bond Index Fund: 452,690 shares worth $23.1M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $61.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q4 2023 buy was Vanguard Tax-Exempt Bond Index Fund: 452,690 shares worth $23.1M.
  • Bailard added most to SPDR Gold Trust in Q4 2023, an estimated $62.8M increase.
  • Bailard's biggest Q4 2023 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $61.4M.
  • Bailard fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $5.5M.
  • Bailard's ten largest holdings make up 29% of its $3.38B portfolio in Q4 2023.
  • Bailard opened 147 new positions and closed 138 in Q4 2023.
  • Bailard's portfolio value rose 12% quarter-over-quarter to $3.38B.

Based on Bailard's 13F filing for Q4 2023, filed 2 Feb 2024.